These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 2457249)

  • 1. [Tumor markers].
    Cappelaere P
    Rev Prat; 1988 Jun; 38(17):1058-63. PubMed ID: 2457249
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum tumor markers.
    Klee GG; Go VL
    Mayo Clin Proc; 1982 Feb; 57(2):129-32. PubMed ID: 6172679
    [No Abstract]   [Full Text] [Related]  

  • 3. [Course studies by means of tumor markers].
    Quentmeier A
    Aktuelle Probl Chir Orthop; 1980; 74():43-6. PubMed ID: 6156606
    [No Abstract]   [Full Text] [Related]  

  • 4. [Sense and nonsense of tumor markers in practice].
    Joss R; Cerny T
    Schweiz Med Wochenschr; 1990 May; 120(19):693-703. PubMed ID: 1693445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor markers: value and limitations in the management of cancer patients.
    Bates SE; Longo DL
    Cancer Treat Rev; 1985 Sep; 12(3):163-207. PubMed ID: 2416441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncofetal and oncoplacental antigens as tumor markers.
    Yamauchi S; Miyake H
    Kitasato Arch Exp Med; 1988 Sep; 61(2-3):95-109. PubMed ID: 2463397
    [No Abstract]   [Full Text] [Related]  

  • 7. [Gastric cancer with bone metastasis from the viewpoint on oncodevelopmental gene products].
    Ohyama S; Yonemura Y; Hashimoto T; Sawa T; Miwa K; Miyazaki I
    Nihon Gan Chiryo Gakkai Shi; 1987 Jun; 22(5):1013-9. PubMed ID: 2447212
    [No Abstract]   [Full Text] [Related]  

  • 8. [A case of alpha-fetoprotein, carcinoembryonic antigen and human chorionic gonadotropin producing renal cell carcinoma].
    Takakura N; Mimura H; Hamazaki K; Kim H; Hirata K; Miwata H; Kimura T; Sakata T; Hosoba T; Orita K
    Gan No Rinsho; 1987 Sep; 33(11):1385-90. PubMed ID: 2444728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Biologic markers of cancer. Towards a selective use for the detection and surveillance of malignant tumors].
    Bellet D; Bidart JM
    Rev Prat; 1989 Nov; 39(26):2350-4. PubMed ID: 2480633
    [No Abstract]   [Full Text] [Related]  

  • 10. Enhanced detection systems for enzyme-linked heterogeneous immunoassays: luminescence.
    Edwards JC; Moon CR
    Immunol Ser; 1990; 53():95-106. PubMed ID: 1713073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological markers of human tumors and monitoring of cancer treatment.
    Tanneberger S; Nissen E; Ziegenbein R
    Arch Geschwulstforsch; 1979; 49(6):528-34. PubMed ID: 94534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in the use of tumor markers.
    Schwartz MK
    Compr Ther; 1990 Nov; 16(11):51-7. PubMed ID: 1702695
    [No Abstract]   [Full Text] [Related]  

  • 13. Tumour markers.
    Pandha HS; Waxman J
    QJM; 1995 Apr; 88(4):233-41. PubMed ID: 7540924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishment and characterization of a seminoma cell-line (S2).
    von Keitz AT; Riedmiller H; Neumann K; Gutschank W; Fonatsch C
    Investig Urol (Berl); 1994; 5():28-31. PubMed ID: 7536523
    [No Abstract]   [Full Text] [Related]  

  • 15. [Tumor markers--possibilities and limitations].
    Rose H; Saul G; Wolf G; Moldenhauer H; Kehrberg G
    Radiobiol Radiother (Berl); 1984; 25(1):7-19. PubMed ID: 6203136
    [No Abstract]   [Full Text] [Related]  

  • 16. [The level of embryonic antigens in the blood serum and cerebrospinal fluid of neuro-oncological patients].
    Rudenko VA; Lisianyĭ NI; Grinevich IuA; Burkatovskaia MB; Iugrinova LG
    Zh Vopr Neirokhir Im N N Burdenko; 1996; (3):32-5. PubMed ID: 8975514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor markers. Key pieces to your cancer patient's clinical picture.
    Ostchega Y; Culnane M
    Nursing; 1985 Sep; 15(9):48-51. PubMed ID: 2410836
    [No Abstract]   [Full Text] [Related]  

  • 18. [Carcinoembryonic antigen, CEA, in colorectal cancer. An insensitive marker which may be excluded from follow-ups].
    Wählby L
    Lakartidningen; 1997 Apr; 94(18):1716-8. PubMed ID: 9182180
    [No Abstract]   [Full Text] [Related]  

  • 19. The clinical usefulness and limitations of tumor markers.
    Torosian MH
    Surg Gynecol Obstet; 1988 Jun; 166(6):567-79. PubMed ID: 2453934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical significance of present tumor markers].
    Ohkura H
    Gan To Kagaku Ryoho; 1993 May; 20(7):843-9. PubMed ID: 7683865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.